Christian Ringemann

This inventor holds 17 USPTO granted patents and 9 published patent applications, plus 3 CIPO patents and 16 EPO patents, primarily in Diabetes Management. Top assignees: Roche Diabetes Care, Inc., Other. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Ringemann. Retrieved from https://idiyas.com/inventor/christian-ringemann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 9)

% Patents Active = 82.4

CIPO Patents = 3 (Patent Applications = 12)

EPO Patents = 16 (Patent Applications = 22)

Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 32(Granted Patents)

Company Filing History:

16 out of 666

Roche Diabetes Care, Inc.

patents

1 out of 834,601

Other

patents

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

Blood Glucose Prediction

Continuous Monitoring

Biosensor Technology

Analyte Detection

Signal Quality Assessment

Diabetes Management Devices

Medical Measurement Evaluation

Risk-Based Control

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12758700 - Method and means for postprandial blood glucose level prediction (2026-10-13),

2. 12731684 - Method and system for generating a software-implemented module for determining an analyte value, computer program product, and method and system for determining an analyte value (2026-09-08),

3. 12042274 - Sensor device for detecting at least one analyte in a body fluid of a user (2024-07-23),

4. 11998321 - System and a method for automatically managing continuous glucose monitoring measurements indicative of glucose level in a bodily fluid (2024-06-04),

5. 11605461 - Risk-based control-to-range blood glucose diabetes management device (2023-03-14),

6. 11280756 - Method for detecting an interferent contribution in a biosensor (2022-03-22),

7. 11096611 - Method for providing a signal quality degree associated with an analyte value measured in a continuous monitoring system (2021-08-24),

8. 11060978 - Methods of determining an analyte concentration in a body fluid sample having disturbance variables, as well as computer programs and devices therefor (2021-07-13),

9. 10984892 - Methods of evaluating medical measurement curves, as well as computer programs and devices therefor (2021-04-20),

10. 10983064 - Method and apparatus for determining the concentration of an analyte in a body fluid (2021-04-20),

11. 10900957 - Method and device for generating a corrected value of an analyte concentration in a sample of a body fluid (2021-01-26),

12. 10791969 - Method and system for method for determining a blood glucose level for a patient (2020-10-06),

13. 10667734 - Method for providing a signal quality degree associated with an analyte value measured in a continuous monitoring system (2020-06-02),

14. 10332633 - Control-to-range aggressiveness (2019-06-25),

15. 10332632 - Control-to-range failsafes (2019-06-25),

Sure, here is the article about inventor Christian Ringemann:

Title: Christian Ringemann: Pioneering Innovations in Diabetes Management

Introduction:

Christian Ringemann is a renowned inventor based in Mannheim, Germany, known for his exceptional contributions to the field of healthcare technology, particularly in the management of diabetes. With a strong background in engineering and biochemistry, Ringemann has garnered recognition for his groundbreaking inventions aimed at revolutionizing diabetes care.

Latest Patents:

Ringemann holds an impressive portfolio of 13 patents, with his latest inventions focusing on risk-based control-to-range blood glucose diabetes management devices. These cutting-edge methods and systems enable personalized treatment for individuals with diabetes by adjusting basal insulin rates based on the associated risks with their glucose levels.

Career Highlights:

Throughout his career, Ringemann has showcased a deep commitment to improving the lives of individuals with diabetes. His innovative solutions, such as the method for detecting interferent contribution in biosensors, have set new standards in the industry. Ringemann's work at companies like Roche Diabetes Care, Inc., and others has been pivotal in advancing diabetes management technologies.

Collaborations:

Collaboration plays a vital role in Ringemann's success, with notable coworkers such as David L Duke and Chinmay Uday Manohar. Together, they have worked tirelessly to bring cutting-edge solutions to the market, enhancing the efficacy and accuracy of diabetes management devices.

Conclusion:

Christian Ringemann's dedication to innovation and his pioneering spirit in the field of healthcare technology have made him a distinguished figure in the realm of diabetes management. His relentless pursuit of excellence continues to shape the future of diabetes care, offering hope and improved quality of life for individuals worldwide.

Profile summary based on public USPTO records.